U.S. Oil and Gas Stock News

The Morning Bull - US Market Morning Update Monday, Feb, 9 2026 E mini S&P 500 futures are slightly higher this morning, with investors eyeing a powerful surge in global tech and chip demand. Taiwan’s exports rose 69.9% year on year in January to US$65.77b, led by electronics and information technology products. This signals strong appetite for the components that sit inside everything from smartphones to data centers. At the same time, China’s foreign exchange reserves stand at US$3.399t,...

United Parcel Service, Inc. ( NYSE:UPS ) will pay a dividend of $1.64 on the 5th of March. This makes the dividend...

In the last year, multiple insiders have substantially increased their holdings of Churchill Downs Incorporated...

Federal Realty Investment Trust recently completed the sale of Misora Apartments, a 212-unit Class A residential community at Santana Row in San Jose, California, alongside the earlier disposition of Courthouse Center in Rockville, Maryland. These transactions, which have generated nearly US$475,000,000 in proceeds over recent quarters, highlight Federal Realty’s ongoing capital recycling program aimed at reinvesting in potentially higher-return properties while maintaining financial...

In January 2026, CVR Partners, LP issued earnings guidance for the past fourth quarter of 2025, projecting a net loss of US$14 million to US$7 million, while estimating full‑year 2025 net income of US$95 million to US$102 million. This contrast between an anticipated quarterly loss and a profitable full year highlights the company’s uneven earnings profile and the importance of timing in its results. We’ll now examine how this guidance, particularly the contrast between a quarterly loss and...

MarketAxess Holdings Inc. ( NASDAQ:MKTX ) will increase its dividend from last year's comparable payment on the 4th of...

The board of Exponent, Inc. ( NASDAQ:EXPO ) has announced that the dividend on 20th of March will be increased to...

With a median price-to-sales (or "P/S") ratio of close to 1.3x in the Consumer Services industry in the United States...

JELD-WEN Holding, Inc. ( NYSE:JELD ) shareholders will doubtless be very grateful to see the share price up 31% in the...

The board of Southside Bancshares, Inc. ( NYSE:SBSI ) has announced that it will pay a dividend of $0.36 per share on...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Most readers would already be aware that Tri Pointe Homes' (NYSE:TPH) stock increased significantly by 10% over the...

Genpact Limited's ( NYSE:G ) dividend will be increasing from last year's payment of the same period to $0.1875 on 31st...

The board of Weis Markets, Inc. ( NYSE:WMK ) has announced that it will pay a dividend on the 3rd of March, with...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

It looks like Provident Financial Holdings, Inc. ( NASDAQ:PROV ) is about to go ex-dividend in the next 2 days. The...

Veradermics stock in focus after recent price move Veradermics (MANE) drew fresh attention after a single day gain of about 3.6%, putting the US$38.48 share price and the company’s dermatology focused pipeline on more investors’ radar. See our latest analysis for Veradermics. The 3.6% one day share price return comes after a relatively muted 1.9% year to date share price return, suggesting interest around Veradermics is picking up only gradually rather than in a sharp momentum shift. If this...

Belite Bio (BLTE) completed enrollment of 60 adolescents in its global Phase 2/3 DRAGON II trial for tinlarebant in Stargardt disease type 1, marking a key clinical milestone that investors often watch closely. See our latest analysis for Belite Bio. The latest clinical milestone comes on top of a strong run in the shares, with Belite Bio’s 30 day share price return of 18.63% and 90 day share price return of 77.63%. Its 1 year total shareholder return of 249.18% and 3 year total shareholder...

If you are wondering whether Zscaler is starting to look attractively priced or still expensive, this article will walk through what the current share price might be implying about its value. The stock last closed at US$167.33, with returns of 16.3% decline over 7 days, 22.8% decline over 30 days, 24.1% decline year to date and 18.6% decline over 1 year, set against a 25.0% gain over 3 years and 26.1% decline over 5 years. Recent news coverage has focused on Zscaler as a key name in cloud...

WesBanco, Inc. recently reported its fourth-quarter and full-year 2025 results, with quarterly net interest income rising to US$222.3 million and net income to US$91.11 million, and also announced that beginning in the first quarter of 2026, dividends on its Series B preferred stock will be US$4.24 million per quarter. An interesting angle for investors is that quarterly earnings per share improved year on year even as full-year earnings per share from continuing operations remained broadly...

In early February 2026, Prestige Consumer Healthcare reported third-quarter fiscal 2026 results showing lower sales and earnings, narrowed full-year revenue guidance to about US$1.10 billion, and detailed continued share repurchases and the recent Pillar5 acquisition amid supply constraints in its Clear Eyes brand. The company highlighted strong free cash flow, reduced leverage, and the flexibility to fund brand investment, selective M&A, and sizeable buybacks at the same time. With recent...

Dianthus Therapeutics, Inc. recently filed a universal shelf registration of up to US$600 million, covering common and preferred stock, debt securities, warrants and units, while also participating in the Guggenheim Emerging Outlook: Biotech Summit 2026 through a CEO fireside chat and investor meetings. This broad financing framework gives the clinical-stage biotech considerable flexibility in how and when it may access capital across different security types. Next, we will examine how the...

Earlier this week, ZoomInfo Technologies (NASDAQ: GTM) reported earnings after previously outperforming revenue expectations and guiding earnings per share ahead of analyst forecasts, while the board granted CEO Henry Schuck a one-time, performance-based option award on 9.7 million shares tied to ambitious targets. This unusually large, performance-linked grant has drawn attention to potential changes in ZoomInfo’s business direction, including sharper execution priorities or the possibility...

Nurix Therapeutics (NRIX) is in focus after reporting full year 2025 earnings that paired revenue of US$83.98 million with a wider net loss of US$264.46 million, alongside a new US$98.8 million shelf registration. See our latest analysis for Nurix Therapeutics. The latest earnings release and shelf registration have arrived after a volatile stretch, with a 31.03% 90 day share price return contrasting with a 12.69% 30 day decline and a 6.44% 1 year total shareholder return fall. This suggests...